Organization
Pfizer SLU
7 abstracts
Abstract
Efficacy and safety of elranatamab in patients with relapsed/refractory multiple myeloma (RRMM) and prior B-cell maturation antigen (BCMA)-directed therapies: A pooled analysis from MagnetisMM studies.Org: Weill Cornell Medical College - New York Presbyterian Hospital, Fox Chase Cancer Center, Arnie Charbonneau Cancer Institute, University of Calgary, Massachusetts General Hospital Cancer Center, Pfizer SLU,
Abstract
Identification of cytokines associated with response and cytokine release syndrome: Analysis of MagnetisMM-3 cohort A.Org: Arnie Charbonneau Cancer Institute, University of Calgary, University of Calgary, Clinica Universidad de Navarra, Pfizer SLU, Pfizer Oncology Division,
Abstract
Genomic analysis to identify determinants of inherent response and resistance to elranatamab in MagnetisMM-3 cohort A.Org: Arnie Charbonneau Cancer Institute, University of Calgary, University of Calgary, St. Vincent’s Hospital, University of Melbourne, University Medical Center of Hamburg-Eppendorf,
Abstract
Efficacy and safety of elranatamab by age and frailty in patients (pts) with relapsed/refractory multiple (RRMM): A subgroup analysis from MagnetisMM-3.Org: Massachusetts General Hospital Cancer Center, Surgical Oncology, Boston, MA, Harvard Medical School, CHU de Poitiers, Hôpital de la Milétrie - Centre Hospitalier Universitaire de Poitiers, Pôle Régional de Cancérologie,
Abstract
Elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, for patients (pts) with relapsed/refractory multiple myeloma (RRMM): Extended follow up and biweekly administration from the MagnetisMM-3 study.Org: Sorbonne University and Saint-Antoine Hospital, Hôpital Saint-Antoine, INSERM UMRs938, Holden Comprehensive Cancer Center, University of Iowa Hospitals & Clinics,
Abstract
ASSOCIATION BETWEEN BASELINE STATIN TREATMENT AND MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF ORAL SURVEILLANCEOrg: Pfizer Inc., Collegeville, PA, United States, Pfizer Turkey, Pfizer SLU, Brigham and Women’s Hospital and Harvard Medical School,
Abstract
BASELINE CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH ANAEMIA IN CLINICAL STUDIES OF TOFACITINIB IN RHEUMATOID ARTHRITISOrg: Pfizer Inc., Collegeville, PA, United States, Pfizer SLU,